A multivalent Plasmodium falciparum circumsporozoite protein‐based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats.

MLA

Pendyala, Geetanjali, et al. “A Multivalent Plasmodium Falciparum Circumsporozoite Protein‐based Nanoparticle Malaria Vaccine Elicits a Robust and Durable Antibody Response against the Junctional Epitope and the Major Repeats.” Bioengineering & Translational Medicine, vol. 8, no. 4, July 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1002/btm2.10514.

APA

Pendyala, G., Calvo, C. J. M., Moreno, A., & Kane, R. S. (2023). A multivalent Plasmodium falciparum circumsporozoite protein‐based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats. Bioengineering & Translational Medicine, 8(4), 1–10. https://doi.org/10.1002/btm2.10514

Chicago

Pendyala, Geetanjali, Calle, J. Mauricio Calvo, Alberto Moreno, and Ravi S. Kane. 2023. “A Multivalent Plasmodium Falciparum Circumsporozoite Protein‐based Nanoparticle Malaria Vaccine Elicits a Robust and Durable Antibody Response against the Junctional Epitope and the Major Repeats.” Bioengineering & Translational Medicine 8 (4): 1–10. doi:10.1002/btm2.10514.